Navigation For Mobile

Category Archives: IP

Neuland News: Patent Awards, New Production Blocks and Quality Management

Patent Awards Neuland recently received two IP awards – IP Gems of India 2018 and IP Excellence in India 2018. These awards were presented to Neuland for the Company’s implementation…

Posted in award, IP, Neuland Labs, Patent, QMS, Quality, Unit III | Comments Off on Neuland News: Patent Awards, New Production Blocks and Quality Management

Neuland Patent Spotlight: Paliperidone Palmitate & Antipsychotics

The use of anti-psychotic drugs to treat conditions such as schizophrenia and bipolar disorder is on the rise and estimated to reach $18.5 billion by 2022. It is a market…

Posted in Chemistry, DMF, generic, IP, Neuland Labs, Patent, process chemistry | Comments Off on Neuland Patent Spotlight: Paliperidone Palmitate & Antipsychotics

Inside Look: The Role of the IPR Department

Intellectual Property Rights and its Importance in Research, Business & Industry We wrote a post on the patent cliff issue back in 2015. The patent cliff has served to further…

Posted in agreement, Contract Manufacturing, IP, method development, Neuland Labs, Patent, technology transfer | Comments Off on Inside Look: The Role of the IPR Department

Advantages of a Pure-Play API Contract Manufacturer

Unlike many API Contract Manufacturing firms, Neuland is pure-play, meaning we do not compete against our clients in the generic formulations market. Differentiating ourselves this way enables us to offer…

Posted in APIs, Contract Manufacturing, CRO/CMO, IP, Patent, process chemistry | Comments Off on Advantages of a Pure-Play API Contract Manufacturer

Intellectual Property Management Group Focuses on API Innovation and Differentiation for Customers

With potential projected losses of $16-32 billion for drugs going off-patent in 2015, intellectual property (IP) is increasingly crucial to keeping a competitive edge in the pharmaceutical and biotechnology markets….

Posted in agreement, API synthesis, APIs, Chemistry, CMC, Contract Manufacturing, CRO/CMO, Freedom to Operate, IP, Patent, R&D, technology transfer | Comments Off on Intellectual Property Management Group Focuses on API Innovation and Differentiation for Customers

100% Pure Pharma APIs? Yes…in a Way.

‘One hundred percent purity’ is the holy grail of pharma – and, more generally, the scientific community. Firms in our industry all around the globe spend the overwhelming majority of…

Posted in APIs, Capabilities, Chemistry, CMC, Contract Manufacturing, IP, method development, Neuland Labs, Patent | Comments Off on 100% Pure Pharma APIs? Yes…in a Way.

Generic Drugs – The Freedom to Operate

In a recent post about contract manufacturing and IP, I discussed how Neuland doesn’t compete with clients in the generics space. A friend in Pharma subsequently asked me my thoughts…

Posted in Contract Manufacturing, Freedom to Operate, IP, Patent | Comments Off on Generic Drugs – The Freedom to Operate